57
94) Stern RS, Laird N, Melski J, Parrish JA, Fitzpatrick TB, Bleich HL. Cutaneous squamous-cell carcinoma in patients treated with PUVA. N Engl J Med 1984; 310: 1156-61.
95) Stern RS, Bagheri S, Nichols K. PUVA follow up study. The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA) for psoriasis. J Am Acad Dermatol 2002; 47: 33-9.
96) McKenna KE, Patterson CC, Handley J, McGinn S, Allen G. Cutaneous neoplasia following PUVA therapy for psoriasis. Br J Dermatol 1996; 134: 639-42.
97) Lindelöf B, Sigurgeirsson B. PUVA and cancer: a case-control study. Br J Dermatol 1993; 129: 39-41.
98) Stern RS. Genital tumors among men with psoriasis exposed to psoralens and ultraviolet A radiation (PUVA) and ultraviolet B radiation. The photochemotherapy follow-up study. N Engl J Med 1990; 322: 1093-7.
99) Kemmett D, Reshad H, Baker H. Nodular malignant melanoma and multiple squamous cell carcinomas in a patient treated by photochemotherapy for psoriasis. Br Med J (Clin Res Ed) 1984; 289: 1498.
100) Rhodes AR, Stern RS, Melski JW. The PUVA lentigo: an analysis of predisposing factors. J Invest Dermatol 1983; 81: 459-63.
101) Friedland R, David M, Feinmesser M, Barzilai A, Hodak E. NB-UVB (311-312 nm)induced lentigines in patients with mycosis fungoides: a new adverse effect of phototherapy. J Eur Acad Dermatol Venereol 2012; 26: 1158-62.
102) Lunder EJ, Stern RS. Merkel-cell carcinomas in patients treated with methoxsalen and ultraviolet A radiation. N Engl J Med 1998; 339: 1247-8.
103) Archier E, Devaux S, Castela E, Gallini A, Aubin F, Le Matre M, Aractingi S, Bachelez H, Cribier B, Joly P, Jullien D, Misery L, Paul C, Ortonne JP, Richard MA. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol 2012; 26: 22-31.
104) Du Vivier A, Vonderheid EC, Van Scott EJ, Urbach F. Mycosis fungoides, nitrogen mustard and skin cancer. Br J Dermatol 1978; 99: 61-3.
105) Ogino J, Saga K, Kagaya M, Kamada A, Hirosaki K, Kaneko R, Jimbow K. CD30+ large cell transformation of mycosis fungoides after psoralen plus ultraviolet A photochemotherapy. Br J Dermatol 2007; 156: 148-51.



66. SAYFAYA BENZER SAYFALAR

Kutanöz T hücreli lenfoma hastalarında periferal kan CD4+ T lenfositlerde CD26 ekspresyonunun akım sitometrik yöntemle araştırılması - Sayfa 83
133-Smoller BR, Detwiler SP, Kohler S, Hoppe RT, Kim YH. Role of histology in providing prognostic information in mycosis fungoides. J Cutan Pathol 1998;25:311-315. 134-Gerami P, Rosen S, Kuzel T, Boone SL, Guitart J. Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma. Arch Dermatol 2008;144:738-746. 135-Kim EJ, Hess S, Richardson SK. Immunopathogenesis and the...
2002-2008 yılları arasında istanbul tıp fakültesi psoriasis polikliniğinde izlenen sistemik tedavi gerektiren psoriasis hastalarının retrospektif incelenmesi - Sayfa 80
28-Lebwohl M, Ali S. (2001): Treatment of psoriasis. Part 2. Systemic therapies. J Am Acad Dermatology, 45,649-60 29-Stern RS, Lange R. (1988): Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment. J Invest Dermatol,91,120-4. 30- Stern RS. (1990): Genital tumors among men with psoriasis exposed to psoralens and ultraviolet A radiation (PUVA) an...

66. SAYFADAKI ANAHTAR KELIMELER

stern
psoralen
acad
dermatol
therapy
study


66. SAYFA ICERIGI

57
94) Stern RS, Laird N, Melski J, Parrish JA, Fitzpatrick TB, Bleich HL. Cutaneous squamous-cell carcinoma in patients treated with PUVA. N Engl J Med 1984; 310: 1156-61.
95) Stern RS, Bagheri S, Nichols K. PUVA follow up study. The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA) for psoriasis. J Am Acad Dermatol 2002; 47: 33-9.
96) McKenna KE, Patterson CC, Handley J, McGinn S, Allen G. Cutaneous neoplasia following PUVA therapy for psoriasis. Br J Dermatol 1996; 134: 639-42.
97) Lindelöf B, Sigurgeirsson B. PUVA and cancer: a case-control study. Br J Dermatol 1993; 129: 39-41.
98) Stern RS. Genital tumors among men with psoriasis exposed to psoralens and ultraviolet A radiation (PUVA) and ultraviolet B radiation. The photochemotherapy follow-up study. N Engl J Med 1990; 322: 1093-7.
99) Kemmett D, Reshad H, Baker H. Nodular malignant melanoma and multiple squamous cell carcinomas in a patient treated by photochemotherapy for psoriasis. Br Med J (Clin Res Ed) 1984; 289: 1498.
100) Rhodes AR, Stern RS, Melski JW. The PUVA lentigo: an analysis of predisposing factors. J Invest Dermatol 1983; 81: 459-63.
101) Friedland R, David M, Feinmesser M, Barzilai A, Hodak E. NB-UVB (311-312 nm)induced lentigines in patients with mycosis fungoides: a new adverse effect of phototherapy. J Eur Acad Dermatol Venereol 2012; 26: 1158-62.
102) Lunder EJ, Stern RS. Merkel-cell carcinomas in patients treated with methoxsalen and ultraviolet A radiation. N Engl J Med 1998; 339: 1247-8.
103) Archier E, Devaux S, Castela E, Gallini A, Aubin F, Le Matre M, Aractingi S, Bachelez H, Cribier B, Joly P, Jullien D, Misery L, Paul C, Ortonne JP, Richard MA. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol 2012; 26: 22-31.
104) Du Vivier A, Vonderheid EC, Van Scott EJ, Urbach F. Mycosis fungoides, nitrogen mustard and skin cancer. Br J Dermatol 1978; 99: 61-3.
105) Ogino J, Saga K, Kagaya M, Kamada A, Hirosaki K, Kaneko R, Jimbow K. CD30+ large cell transformation of mycosis fungoides after psoralen plus ultraviolet A photochemotherapy. Br J Dermatol 2007; 156: 148-51.

İlgili Kaynaklar

single.php